EWTX

Edgewise Therapeutics, Inc. is a biopharmaceutical innovator based in Boulder, Colorado, specializing in the development of cutting-edge small molecule therapies for musculoskeletal diseases. Leveraging its proprietary technology platform, the company aims to provide precision medicine solutions that target critical unmet medical needs, particularly in muscle disorders and bone injuries. With a promising pipeline of transformative therapies, Edgewise Therapeutics is strategically positioned to enhance patient outcomes and revolutionize treatment approaches within the orthopedic landscape, underscoring its commitment to advancing musculoskeletal health.